Patents Assigned to Denali Biotechnologies, Inc.
  • Patent number: 8591964
    Abstract: This invention relates to novel compositions comprising as an active ingredient one or more berries, leaves, roots, and/or root barks obtained from one or more plant species of the genus Vaccinium, wherein said plant(s) is/are grown under the following conditions: a. Subject to one or more uninterrupted photoperiod(s) of at least about 18 hours to 24 hours per day for about 60 days during flowering and fruit setting; and; b. Subject to one or more uninterrupted photoperiod(s) of at least about 15 hours per day for about 30 days during fruit ripening and maturity. More particularly, said plant(s) is/are optionally grown at least 7 days past maturity. Further, the compositions of the inventive subject matter optionally may include an additional element comprising an oil from Oncorhynchus species. Further, said compositions may be employed to treat a variety of diseases, disorders, and conditions, as described herein.
    Type: Grant
    Filed: April 3, 2003
    Date of Patent: November 26, 2013
    Assignee: Denali Biotechnologies, Inc.
    Inventor: Maureen McKenzie